Education
About Us
Working with TipRanks
Follow Us
HeraMED Ltd. (AU:HMD)
:HMD
HMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.03
Previous CloseN/A
Volume370.09K
Average Volume (3M)555.38K
Market Cap
AU$16.64M
Enterprise ValueN/A
Total Cash (Recent Filing)AU$723.29K
Total Debt (Recent Filing)$209.37K
Price to Earnings (P/E)―
Beta0.33
Next Earnings
Sep 02, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding875,602,700
10 Day Avg. Volume712,753
30 Day Avg. Volume555,381
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
HeraMED Ltd. News
PremiumCompany Announcements
HeraMED Refines US Strategy Amid Healthcare Policy Shifts
PremiumCompany Announcements
HeraMED Ltd. Initiates Trading Halt Ahead of Major Announcement
PremiumCompany Announcements
HeraMED Limited Schedules Annual General Meeting for May 2025
PremiumCompany Announcements
HeraMED Limited Announces AGM Date and Director Nomination Deadline
PremiumCompany Announcements
HeraMED to Showcase Innovations at NWR Virtual Healthcare Conference
PremiumCompany Announcements
HeraMED Ltd. Releases 2024 Corporate Governance StatementPremiumCompany Announcements
HeraMED Ltd. Releases 2024 Annual Report Highlighting Strategic Growth
PremiumCompany Announcements
HeraMED Ltd. Reports Revenue Decline and Improved Net Loss for 2024---
HMD FAQ
What was HeraMED Ltd.’s price range in the past 12 months?
HeraMED Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is HeraMED Ltd.’s market cap?
HeraMED Ltd.’s market cap is AU$16.64M.
When is HeraMED Ltd.’s upcoming earnings report date?
HeraMED Ltd.’s upcoming earnings report date is Sep 02, 2025 which is in 106 days.
How were HeraMED Ltd.’s earnings last quarter?
HeraMED Ltd. released its earnings results on Feb 26, 2025. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.003.
Is HeraMED Ltd. overvalued?
According to Wall Street analysts HeraMED Ltd.’s price is currently Overvalued.
Does HeraMED Ltd. pay dividends?
HeraMED Ltd. does not currently pay dividends.
What is HeraMED Ltd.’s EPS estimate?
HeraMED Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HeraMED Ltd. have?
HeraMED Ltd. has 875,602,700 shares outstanding.
What happened to HeraMED Ltd.’s price movement after its last earnings report?
HeraMED Ltd. reported an EPS of -AU$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10%.
Which hedge fund is a major shareholder of HeraMED Ltd.?
Currently, no hedge funds are holding shares in AU:HMD
---
HeraMED Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
AU:HMD Sentiment 50%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
―
20 days / 200 days
Momentum
10.00%
12-Months-Change
Fundamentals
Return on Equity
-321.94%
Trailing 12-Months
Asset Growth
47.03%
Trailing 12-Months
Company Description
HeraMED Ltd.
HeraMED Limited, together with its subsidiaries, develops, manufactures, and sells foetal heart beat monitors and other pregnancy monitoring solutions for home use in Australia, Europe, and Israel. The company provides HeraBEAT, a fetal heart rate monitor use by an expectant mother to monitor their fetus' heartbeat; and HeraCARE, a digital pregnancy monitor platform for the creation and implementation of digital health solutions for maternity care management. It also develops EchoBEAT, the next generation of its home-oriented pregnancy monitoring devices; and Orion, an artificial intelligence powered pregnancy monitoring system for pregnancy monitoring analysis. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform. HeraMED Limited was incorporated in 2011 and is headquartered in Netanya, Israel.
---
Technical Analysis
Telix Pharmaceuticals
―
Compumedics Limited
―
Resonance Health Ltd
―
Polynovo
―
IDT Australia Limited
―
---